Emiliano Calvo Aller

43PUBLICATIONS
318CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsPharmacogenomicsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Sep 07, 2026
Phase 1/1b open-label, first-in-human study of HER2×CD3×CD28 trispecific T-cell engager (SAR443216) in participants with R/R HER2-expressing solid tumors.

|Jul 23, 2026
Vobramitamab duocarmazine, an anti-B7-H3 antibody-drug conjugate, in patients with advanced solid tumors: Final results of a phase 1 cohort expansion.

|Jul 13, 2026
An anti-PMEL antibody-drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial.

|Jun 01, 2026
Integrating antibody-drug conjugates into solid tumor oncology: Current standards and future directions.

|May 29, 2026
Human Absorption, Metabolism, and Excretion (hAME) Mass Balance Studies in Patients With Cancer.

|May 23, 2026
Safety and Efficacy of HexaBody-DR5/DR5 in Malignant Solid Tumors: Phase 1/2a Results and Translational Insights Into Observed Hepatotoxicity.

Pageof 8

Frequent Collaborators

14 joint publications

Victor Moreno

9 joint publications

Ignacio Melero

8 joint publications

Elena Garralda

5 joint publications

Tatiana Hernandez-Guerrero